Treating Relapsing MS With Ocrelizumab
Ocrelizumab for Relapsing MS
Response to Cladribine Tablets in RRMS
Repository Corticotropin Injection for RRMS
Relapse Recovery and Outcomes in MS
Repository Corticotropin Injection for Relapsing MS
The Gut Microbiota and Risk of Relapse in MS
Goals of Therapy for Relapsing MS
Escalation Versus Induction Therapy in Relapsing Multiple Sclerosis
Steven Shook, MD: Managing Patients Via Telemedicine
The staff neurologist, Vice-Chair of Operations, and Quality Improvement Officer at Cleveland Clinic Neurological Institute detailed his experience managing patients with various conditions through a telemedicine platform.
Jennifer Frontera, MD: Reaction to COVID-19 Data
The professor of neurology at NYU Langone shares her thoughts on the clinical data that has been released so far on patients with COVID-19.
COVID-19 Stroke Recommendations, Nusinersen New SMA Results, Upcoming 2020 CMSC Virtual Annual Meeting
Neurology News Network for the week ending May 23, 2020.
Mark Freedman, MD: An Update on Stem Cell Research in MS
The director of the multiple sclerosis research unit at Ottawa Hospital discussed stem cell therapies being explored in multiple sclerosis, and which patients may be eligible for these treatments.
The Future of Multiple Sclerosis Management
Novel Oral Therapy for MS: AAN Data Updates
AAN 2020 Data Release: Ofatumumab for Relapsing MS
Treating Patients With MS During the COVID-19 Pandemic
MS Treatment Optimization During COVID-19
Multiple Sclerosis: Takeaways From AAN 2020
AAN 2020: Real-World Data on Cladribine Tablets for MS
Disease-Modifying Therapies for MS During COVID-19
Multiple Sclerosis and Risk of COVID-19
Optic Neuritis Take-Home Message
Optic Neuritis and Multiple Sclerosis Management During COVID-19
ACTH Neuroprotection in Acute Optic Neuritis
High-Contrast Visual Acuity Test and Optic Neuritis
MOG and Neuromyelitis Optica
Treatment Options for Optic Neuritis and Multiple Sclerosis
Optic Neuritis and Brain Lesions
Diagnosis of Optic Neuritis
